Avastin: Helpful drug or too risky, expensive?

In an “Urgent Submission on Breast Cancer” to newspaper editors, Sally C. Pipes (president and CEO of the Pacific Research Institute and author of “The Truth About Obamacare”) outlined only the positive parts of the Avastin story and implied that saving money was the real reason for this recommendation. She states, “One can only hope that the Obama Administration defends a woman’s right to choose Avastin.”

Read more at https://www.fwdailynews.com/index.php?option=com_content&view=article&id=9044:Avastin:-Helpful-drug-or-too-risky,-expensive?&catid=100:terry-gaff.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Subscribe to our newsletter:

This field is for validation purposes and should be left unchanged.
Scroll to Top